Hadassah

Gender Makes Difference in Medicine

Tuesday, Feb 9 2016

“Gender, biological sex, and sex hormones affect each and every facet of the practice of medicine,” Dr. Anat Biegon, visiting lecturer at the Hadassah Medical Center, told her audience. “They affect the prevalence of disease, disease presentation, disease outcomes, response to medical devices and procedures and, in a major way, response to drugs.”

In her presentation entitled “Sex Differences in Medicine: Why Should We Care?” Dr. Biegon, Professor of Neurology and Radiology and Director of the Center on Gender, Hormones, and Health at Stony Brook (NY) University School of Medicine, emphasized also the importance of taking the age of a woman into account. During the course of a woman’s life, she explained, as a woman’s reproductive hormones fluctuate, the risk of disease can rise and ebb.

Dr. Biegon stressed too that “Women are more likely to suffer adverse effects from drugs across drug classes.”  By the same token, she brought out, “many drugs are likely to be ineffective in women.” She cited the large study of 40,000 women which revealed that taking aspirin does help prevent heart attacks in women, but only for those over 65, despite the fact that it has a significant preventative effect for all men.

Read more about her lecture in The Jerusalem Post.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More